Hereditary angioedema (HAE) is a rare disease that causes painful, unpredictable, and potentially life-threatening episodes of subcutaneous or mucosal swelling. Attacks can be a source of stress, anxiety, and may interfere with a person’s ability to live a normal life. In this activity, a patient-provider panel sheds light on the challenges of living with HAE and the promise emerging therapies hold for this patient population.
Upon completion of this activity, participants should be better able to:
Professor, Medicine
HAE Community Endowed Chair
Clinical Director, US HAEA Angioedema Center
Clinical Service Chief and Training Program Director Division of Rheumatology, Allergy & Immunology
University of California, San Diego
San Diego, CA
Clinical Professor, Internal Medicine
University of Texas Southwestern Medical School
Dallas, TX
RMEI Medical Education, LLC (RMEI) requires instructors, planners, managers, and others in control of educational content to disclose all their financial relationships with ineligible companies over the previous 24 months. All identified financial relationships are thoroughly vetted and mitigated according to RMEI policy.
William R. Lumry, MD, has relevant financial relationships with Astria, BioCryst, BioMarin, CSL Behring, Express Scripts CVS, Intellia, Kalvista, Magellan, Optum, Pharming, Pharvaris, Shire/Takeda (Consultant); AstraZeneca, BioCryst, CSL Behring, Grifols, GSK, Kalvista, Pharming, Sanofi/Regeneron, Shire/Takeda (Speaker); AstraZeneca, Astria, BioMarin, CSL Behring, Grifols, Intellia, Ionis, Kalvista, Lilly, Novartis, Pharvaris, Shire/Takeda, Teva, Upstream Bio (Grants/Research Support).
Marc A. Riedl, MD, MS, has relevant financial relationships with Astria, BioCryst, BioMarin, Celldex, CSL Behring, Cycle Pharma, Grifols, Intellia, Kalvista, Novartis, Pfizer, Pharming, Pharvaris, Sanofi-Regeneron, Takeda (Consultant); CSL Behring, Grifols, Pharming, Takeda (Speaker); Astria, BioCryst, BioMarin, CSL Behring, Ionis, Kalvista, Pharvaris, Takeda (Researcher).
Patient participating in this activity has no relevant financial relationship(s) with ineligible companies to disclose.
All of the relevant financial relationships listed for these individuals have been mitigated according to RMEI policies.
In support of improving patient care, RMEI Medical Education, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
RMEI Medical Education, LLC designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Pharmacy Education
RMEI Medical Education, LLC designates this continuing education activity for 1.5 contact hour(s) (0.15 CEUs) of the Accreditation Council for Pharmacy Education.
(Universal Activity Number — JA4008290-0000-25-003-H01-P)
Type of Activity: Knowledge
Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.5 contact hours.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.5 medical knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
To receive credit, participants must review the activity content and successfully complete both the post-test and evaluation. A statement of credit will be available to print immediately. You must score 80% or higher on the post-test to receive credit for this activity. If you have questions about this activity, please contact RMEI at [email protected].
Users must:
There is no fee to participate.
In order to claim MOC points, users must:
MOC points will be submitted to ABIM profiles within 6 to 8 weeks of completion.
For Pharmacists: You must provide your NABP eProfile ID and Date of Birth (MMDD format) in order to receive credit for the activity.
COMPLETE THE EVALUATION FORM AND YOU WILL BE ENTERED INTO A DRAWING
FOR A $100* AMAZON GIFT CARD!
*The expense for this gift card is solely funded by RMEI Medical Education, LLC.
No supporter funding was used for the expense of this gift card.
This sweepstakes is managed by RMEI Medical Education, LLC (RMEI), a jointly accredited provider. The winner will be selected via automated random drawing on a quarterly basis from among all eligible entries and notified through the contact information provided. In accordance with our privacy policy, we do not share your information with any third parties. By entering the sweepstakes, you grant RMEI permission to use your e-mail address to reach you for notification and prize fulfillment. Only individuals who complete the evaluation form and provide contact information will be eligible to win. Open to those who have a US postal address and who are 18 years or older. Only one prize per person and per household will be awarded. The prize will be a $100 Amazon gift card
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Featured RMEI CE Activities
Stay up to date with the latest RMEI CE Activities and receive Exclusive Medical Education Resources
